Navigation Links
Microchip Biotechnologies, Inc. Awarded Contract Under US Army Commercialization Pilot Program
Date:9/17/2008

DUBLIN, Calif., Sept. 17 /PRNewswire/ -- Microchip Biotechnologies, Inc. (MBI) has been awarded a $625,000 contract under the inaugural US Army Commercialization Pilot Program for the development of a Universal Sample Preparation Module (USPM). The Commercialization Pilot Program is a new program to assist SBIR firms that have Phase II projects that meet high priority Army requirements in transitioning to commercial products.

MBI's project will develop a Universal Sample Preparation Module that will automatically purify DNA from pathogen targets contained in complex matrices to provide samples for various downstream DoD-sponsored analytical platforms. The USPM will enable front-end sample preparation with high specificity for rapid detection, identification, and diagnosis of biological threat agents and will be applicable to detecting pathogens for molecular diagnostics. Using MBI's Microscale On-chip Valves (MOV(TM)) technology, the USPM will integrate multiple sample processing steps in a small, universal sample preparation module that integrates immunomagnetic separation capture with lysis and nucleic acid purification.

"Easy-to-use sample preparation, under field conditions, has always been a major obstacle to deploying back end pathogen detection and identification devices as well as molecular diagnostics devices. The USPM will greatly simplify this process and improve detection sensitivity," said Dr. Joanne Horn, Project Manager, heading the USPM development at MBI.

About Microchip Biotechnologies Inc.

Microchip Biotechnologies, Inc. (MBI) is developing the Apollo next-generation fluidics platform for Life Sciences, Applied Sciences, and Diagnostics markets. The Apollo platform incorporates MBI's proprietary BeadStorm(TM). bead-based sample preparation devices and patented "Microscale On-chip Valves" (MOV(TM)) valves, pumps, and routers on microchips to integrate, automate, and simplify workflows. The Company's first product,
'/>"/>

SOURCE Microchip Biotechnologies, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. Microchip Biotechnologies, Inc. Secures Exclusive License to Use New University of Alberta Technology for Developing Microfluidic Devices
2. Quick microchip test for dangerous antibiotic resistant bacteria
3. Team develops energy-efficient microchip
4. Microchip Biotechnologies, Inc. Collaborating With Stanford University on Developing a Front End Microfluidic-Based Sample Preparation System for Pyrosequencing Platforms
5. Canadian Centre for DNA Barcoding to Participate in Microchip Biotechnologies Early Access Program for Microchip-Based DNA Sample Preparation and Cycle Sequencing
6. Microchip Biotechnologies, Inc. Enters Into License Arrangement With GE Healthcare for Fundamental Microfluidic Patents
7. Melting defects could lead to smaller, more powerful microchips
8. MIT reports finer lines for microchips
9. Maven Biotechnologies, LLC to Present at BIOCOM Investor Conference
10. Millennium Biotechnologies, Inc. Launches SURGEX(TM) the First Scientifically Validated Sports Nutritional Product Created from the Medical Markets
11. Raven biotechnologies, inc. and Wyeth Pharmaceuticals Extend Evaluation Period of Selected Raven Antibodies
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/21/2013)... Lindsley F. Kimball Research Institute of the New York Blood ... Explorations winner, an initiative funded by the Bill ... , Head of the Laboratory of Molecular Parasitology will ... Innovative 3-D in vitro culturing system for ... to help eliminate onchocerciasis (river blindness) in Africa ...
(Date:5/21/2013)... 2013 Alpha Source, Inc., a ... be exhibiting for the 13th consecutive year at ... (AAMI) 2013 Conference and Expo. The conference brings ... manufacture healthcare technologies. This year’s event will be ... , The three-day event draws over 1,500 ...
(Date:5/21/2013)... Smarter Security, Inc., provider of premium, ... that Genzyme, a Sanofi company and leading biotech company, ... for a multi-use facility in the United States. With ... buildings, this latest order underscores the satisfaction and success ... device improving doorway access control. , “We ...
(Date:5/21/2013)... 2013 Emerson Resources Inc. , ... Charles Signorino, the Company’s Chief Executive Officer and Chairman ... 32 years of service. As part of Emerson Resources’ ... has been named as Dr. Signorino’s successor. , ... industry, having made a significant contribution to the field ...
Breaking Biology Technology:New York Blood Center's Research Institute Receives Grand Challenges Explorations Grant For Groundbreaking Research in Global Health and Development 2New York Blood Center's Research Institute Receives Grand Challenges Explorations Grant For Groundbreaking Research in Global Health and Development 3Alpha Source, Inc. to Exhibit at the AAMI 2013 Conference and Expo 2Door Security at Genzyme, a Sanofi Company, Enhanced with Door Detective from Smarter Security 2Door Security at Genzyme, a Sanofi Company, Enhanced with Door Detective from Smarter Security 3Emerson Resources Announces CEO Retirement and Appointment of Successor 2Emerson Resources Announces CEO Retirement and Appointment of Successor 3
... Bavarian Nordic, the,Danish-based biopharmaceutical company, recently published its ... significant matters in the report,as well as events after ... the year 2007 was DKK 332.1 million with,a loss ... line with the Company,s,latest guidance. For 2008, Bavarian Nordic ...
... finds that physicians place importance on ... indication-specific FDA approval, WALTHAM, ... US Department of Justice into the marketing of biliary,stents for ... use in specific arteries could become a key focus for,stent ...
... Pharmaceutical,companies currently challenged with replacing the $65 billion ... the next four years must dramatically,rethink their R&D ... report,released by Deloitte today., According to the ... the Future,Pharmaceutical Landscape (http://www.deloitte.com/us/FuturePharma ), current R&D,programs ...
Cached Biology Technology:Bavarian Nordic Update - 2007 Annual Results, IMVAMUNE(R) Delivery Contract, Strategy Process 2Bavarian Nordic Update - 2007 Annual Results, IMVAMUNE(R) Delivery Contract, Strategy Process 3Bavarian Nordic Update - 2007 Annual Results, IMVAMUNE(R) Delivery Contract, Strategy Process 4Bavarian Nordic Update - 2007 Annual Results, IMVAMUNE(R) Delivery Contract, Strategy Process 5Bavarian Nordic Update - 2007 Annual Results, IMVAMUNE(R) Delivery Contract, Strategy Process 6Bavarian Nordic Update - 2007 Annual Results, IMVAMUNE(R) Delivery Contract, Strategy Process 7Bavarian Nordic Update - 2007 Annual Results, IMVAMUNE(R) Delivery Contract, Strategy Process 8Bavarian Nordic Update - 2007 Annual Results, IMVAMUNE(R) Delivery Contract, Strategy Process 9Off-Label Stent Use: How Important Are FDA Approvals to Physicians? 2As Billions in Blockbuster Drug Revenue Goes Off Patent, Life Sciences Companies are Challenged to Fundamentally Change Future R&D Strategies, According to New Deloitte Report 2As Billions in Blockbuster Drug Revenue Goes Off Patent, Life Sciences Companies are Challenged to Fundamentally Change Future R&D Strategies, According to New Deloitte Report 3
(Date:5/18/2013)... (May 18, 2013) An increasing number of ... interventions to resolve, according to research presented at ... study targeting obesity, researchers at the Cleveland Clinic ... unique pattern of exhaled breath compared to their ... organic compound levels that can be correlated to ...
(Date:5/17/2013)... the white noise of the South, but the night belongs ... air hangs heavy from the humidity and the sounds of ... species of frogs, toads and salamanders, is the center of ... swamps are the auditorium for their symphonic choruses, the scientists ... or ARMI, have front-row seats. , Amphibians, which ...
(Date:5/17/2013)... the science and technology of the region and ... inaugural Atlanta Science Festival, March 22-29, 2014. With ... K-12 schools and universities, the festival will host ... adults at venues across the city. Learn more ... Atlanta Science Festival is a collaboration of scientific, ...
Breaking Biology News(10 mins):New research identifies risks, interventions for children's GI health 2New research identifies risks, interventions for children's GI health 3Front-row seats to climate change 2Front-row seats to climate change 3Front-row seats to climate change 4First Atlanta Science Festival set for 2014 2
... Frontier Science Program Organization (HFSPO) is pleased to announce ... upon Karl Deisseroth of Stanford University for his pioneering ... for the study of the relationship between neural circuits ... to honour scientists who have made key breakthroughs in ...
... Coastal and Marine Laboratory has won a three-year, $674,989 ... numbers are believed to have declined globally more than ... the stingrays but more closely resembles a shark. It ... due to the commercial appeal of its prominent, toothy ...
... Va.The Society of Interventional Radiology and Custom Computer ... licensing agreement to promote innovation and the development ... interventional radiology. "We are thrilled to have ... competitive, track outcomes and monitor the quality of ...
Cached Biology News:The first HFSP Nakasone award goes to Karl Deisseroth of Stanford University 2FSU marine ecologist wins grant to study endangered sawfish 2FSU marine ecologist wins grant to study endangered sawfish 3Society of Interventional Radiology, Custom Computer Specialists announce HI-IQ licensing agreement 2
High voltage electrophoresis power supply...
Rab GDP dissociation inhibitor beta...
The Programmable MP-3500P-F Power Supply can be applied for any Microfluidic application....
BD BioCoat Collagen IV 35 mm Culture Dishes, tissue-culture treated polystyrene with a uniform application of mouse collagen type IV....
Biology Products: